Amongst other infiltrating immune cell types, it is widely known that the IDH mutation leads to drastically altered tumor immunology, notably decreased CD8 and CD4 T-cell numbers and infiltration into the tumor tissue compared to IDH-wild type cases [18,39,41]. This evidence concerns the gene IDH1 and neoplasm.